JP2000516589A5 - - Google Patents

Download PDF

Info

Publication number
JP2000516589A5
JP2000516589A5 JP1998508453A JP50845398A JP2000516589A5 JP 2000516589 A5 JP2000516589 A5 JP 2000516589A5 JP 1998508453 A JP1998508453 A JP 1998508453A JP 50845398 A JP50845398 A JP 50845398A JP 2000516589 A5 JP2000516589 A5 JP 2000516589A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998508453A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000516589A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP1997/003889 external-priority patent/WO1998004552A1/en
Publication of JP2000516589A publication Critical patent/JP2000516589A/ja
Publication of JP2000516589A5 publication Critical patent/JP2000516589A5/ja
Ceased legal-status Critical Current

Links

JP10508453A 1996-07-29 1997-07-19 細胞増殖阻害のための置換ビスインドリルマレイミド Ceased JP2000516589A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2207996P 1996-07-29 1996-07-29
US60/022,079 1996-07-29
PCT/EP1997/003889 WO1998004552A1 (en) 1996-07-29 1997-07-19 Substituted bisindolylmaleimides for the inhibition of cell proliferation

Publications (2)

Publication Number Publication Date
JP2000516589A JP2000516589A (ja) 2000-12-12
JP2000516589A5 true JP2000516589A5 (Direct) 2005-03-10

Family

ID=21807711

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10508453A Ceased JP2000516589A (ja) 1996-07-29 1997-07-19 細胞増殖阻害のための置換ビスインドリルマレイミド

Country Status (23)

Country Link
US (2) US5856517A (Direct)
EP (1) EP0915872B1 (Direct)
JP (1) JP2000516589A (Direct)
KR (1) KR20000029637A (Direct)
CN (2) CN1495182A (Direct)
AR (1) AR008267A1 (Direct)
AT (1) ATE240318T1 (Direct)
AU (1) AU739742B2 (Direct)
BR (1) BR9711605A (Direct)
CA (1) CA2262092A1 (Direct)
CO (1) CO4900055A1 (Direct)
CY (1) CY2483B1 (Direct)
DE (1) DE69722003T2 (Direct)
DK (1) DK0915872T3 (Direct)
ES (1) ES2198001T3 (Direct)
HR (1) HRP970414A2 (Direct)
MA (1) MA24287A1 (Direct)
PE (1) PE91698A1 (Direct)
PT (1) PT915872E (Direct)
SA (1) SA97180473A (Direct)
TR (1) TR199900157T2 (Direct)
WO (1) WO1998004552A1 (Direct)
ZA (1) ZA976492B (Direct)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE243693T1 (de) * 1998-03-17 2003-07-15 Hoffmann La Roche Substituierte bisindolylmaleimide zur inhibierung der zellproliferation
WO2001044235A2 (en) * 1999-12-16 2001-06-21 Eli Lilly And Company Agents and methods for the treatment of proliferative diseases
EP1242420A2 (en) 1999-12-16 2002-09-25 Eli Lilly And Company Agents and methods for the treatment of proliferative diseases
US6313143B1 (en) * 1999-12-16 2001-11-06 Hoffmann-La Roche Inc. Substituted pyrroles
US6743785B2 (en) * 1999-12-16 2004-06-01 Eli Lilly And Company Agents and methods for the treatment of proliferative diseases
US6281356B1 (en) 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
TW201041580A (en) 2001-09-27 2010-12-01 Alcon Inc Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
US20030139373A1 (en) * 2001-11-20 2003-07-24 Breimer Lars Holger Method for cancer therapy
MY142390A (en) * 2002-05-22 2010-11-30 Glaxosmithkline Llc 3' - [(2z)-[1-(3,4-dimethylphenyl)-1,5- dihydro-3- methyl-5-0xo-4h-pyrazol-4- ylidene]hydrazino]-2' -hydroxy -[1,1' -biphenyl]-3-carboxylic acid bis-(monoethanolamine)
US7012100B1 (en) * 2002-06-04 2006-03-14 Avolix Pharmaceuticals, Inc. Cell migration inhibiting compositions and methods and compositions for treating cancer
DK1846406T5 (da) 2005-02-09 2011-10-31 Arqule Inc Maleimidderivater, farmaceutiske sammensætninger og fremgangsmåder til behandling af cancer
BRPI0720388A2 (pt) * 2006-12-19 2014-01-14 Novartis Ag Derivados de indolilmaleimida
JP5425060B2 (ja) 2007-06-22 2014-02-26 アークル インコーポレイテッド ピロリジノン、ピロリジン−2,5−ジオン、ピロリジンおよびチオスクシンイミド誘導体、癌の治療のための組成物および方法
BRPI0813355A2 (pt) 2007-06-22 2014-12-30 Arqule Inc Compostos de quinazolinona e métodos de uso dos mesmos
US8513292B2 (en) 2007-06-22 2013-08-20 Arqule, Inc. Compositions and methods for the treatment of cancer
JP2009035537A (ja) * 2007-07-10 2009-02-19 Nippon Synthetic Chem Ind Co Ltd:The N−置換アニリン誘導体及び1−置換インドール誘導体の製造方法
FR2927075A1 (fr) * 2008-02-04 2009-08-07 Centre Nat Rech Scient Molecules comprenant un squelette bis-(heteroaryl)maleimide, et leur utilisation dans l'inhibition d'enzymes
GB201111427D0 (en) * 2011-07-05 2011-08-17 Amakem Nv Novel bisindolylmaleimides, pan-pkc inhibitors
CA2939219C (en) 2014-02-11 2023-02-28 Mitokinin Llc Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
US20170209488A1 (en) 2014-07-17 2017-07-27 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods for treating neuromuscular junction-related diseases
WO2016207366A1 (en) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of viral infections
KR20200019228A (ko) 2017-06-21 2020-02-21 미토키닌, 인크. 신경퇴행성 및 미토콘드리아 질환의 치료를 위한 조성물 및 이를 사용하는 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ280738B6 (cs) * 1988-02-10 1996-04-17 F. Hoffmann - La Roche And Co., Aktiengesellschaft Substituované pyrroly, jejich použití pro výrobu léčiv a léčiva na jejich bázi
PT93947B (pt) * 1989-05-05 1996-11-29 Goedecke Ag Processo para a preparacao de novos derivados de maleinimidas e de composicoes farmaceuticas que os contem
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
DE4005969A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte pyrrole, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
JPH0539289A (ja) * 1991-02-15 1993-02-19 Masahiro Irie 無水マレイン酸誘導体およびその製造方法
EP0630241A1 (en) * 1992-03-20 1994-12-28 The Wellcome Foundation Limited Indole derivatives with antiviral activity
DE4217964A1 (de) * 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung

Similar Documents

Publication Publication Date Title
JP2000502280A5 (Direct)
JP2000516370A5 (Direct)
JP2001505081A5 (Direct)
JP2000508561A5 (Direct)
JP2000512744A5 (Direct)
JP2000501771A5 (Direct)
JP2000501599A5 (Direct)
JP2000500076A5 (Direct)
JP2000500055A5 (Direct)
JP2000500026A5 (Direct)
JP2000502472A5 (Direct)
JP2000501825A5 (Direct)
JP2001502959A5 (Direct)
JP2000502425A5 (Direct)
JP2000502485A5 (Direct)
JP2001507002A5 (Direct)
JP2000502568A5 (Direct)
JP2000501774A5 (Direct)
JP2000502570A5 (Direct)
JP2000501876A5 (Direct)
JP2000501744A5 (Direct)
JP2000502316A5 (Direct)
JP2000502714A5 (Direct)
JP2001506750A5 (Direct)
JP2000501569A5 (Direct)